RecruitingNot ApplicableNCT06956040
Involvement of General Practitioners in Lung Cancer Screening
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
500 participants
Start Date
Jun 2, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The main objective is to evaluate the adherence of smoking patients to lung cancer screening by low-dose CT scan, when proposed by the general practitioner.
Eligibility
Min Age: 50 YearsMax Age: 74 Years
Plain Language Summary
Simplified for easier understanding
This study tests whether having your family doctor (general practitioner) actively involved in a lung cancer screening program — using low-dose CT scans — improves participation rates and outcomes in people at high risk for lung cancer due to heavy smoking history.
**You may be eligible if...**
- You are between 50 and 74 years old
- You are a current smoker or you stopped smoking less than 15 years ago
- You have smoked heavily — at least 20 pack-years (e.g., 1 pack per day for 20 years)
- You are registered with a social security scheme in France
**You may NOT be eligible if...**
- You have a history of lung cancer
- You had a chest CT scan within the past year
- You are unable to travel independently to a participating hospital for scans
- You have severe health problems that would prevent treatment of any detected lung cancer
- You have significant breathing difficulty at rest
- You have recently lost a lot of weight, feel very unwell, or have been coughing up blood (which may suggest active cancer requiring immediate attention)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURELow-dose computed tomography of the chest
Baseline low dose Ct acquisition, then at 1 year to depict suspicious lung nodules
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06956040
Related Trials
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
NCT048999082 locations
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung Cancer
NCT056329131 location
CARE Tool Study Aim 3
NCT072968873 locations
CHAMP Lung Cancer Screening Program
NCT075727733 locations
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
NCT0605169512 locations